Trials / Terminated
TerminatedNCT00295776
Lamictal in the Treatment of Post-Herpetic Neuralgia
Lamictal in the Treatment of Post-Herpetic Neuralgia-A Safety, Efficacy,Randomized, Double Blind, Placebo Controlled, Cross-Over Study
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- George Washington University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
To assess the efficacy of Lamictal for the treatment of pain and reduction of allodynia in patients with post herpetic neuralgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lamictal in the treatment of Post-Herpetic Neuralgia |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2007-12-01
- First posted
- 2006-02-24
- Last updated
- 2013-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00295776. Inclusion in this directory is not an endorsement.